1-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propan-2-yl 6-bromopyrrolo[3,2-b]pyridine-1-carboxylate
C17H22BrN3O4 — CID 154645958
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propan-2-yl 6-bromopyrrolo[3,2-b]pyridine-1-carboxylate
1-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propan-2-yl 6-bromopyrrolo[3,2-b]pyridine-1-carboxylate (PubChem CID 154645958) has the molecular formula C17H22BrN3O4 and a molecular weight of 412.28 g/mol. Its IUPAC name is 1-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propan-2-yl 6-bromopyrrolo[3,2-b]pyridine-1-carboxylate.
Molecular Properties
| Compound Name | 1-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propan-2-yl 6-bromopyrrolo[3,2-b]pyridine-1-carboxylate |
|---|---|
| PubChem CID | 154645958 |
| Molecular Formula | C17H22BrN3O4 |
| Molecular Weight | 412.28 g/mol |
| Exact Mass | 411.08 |
| IUPAC Name | 1-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propan-2-yl 6-bromopyrrolo[3,2-b]pyridine-1-carboxylate |
| SMILES | CC(CN(C)C(=O)OC(C)(C)C)OC(=O)n1ccc2ncc(Br)cc21 |
| InChI | InChI=1S/C17H22BrN3O4/c1-11(10-20(5)15(22)25-17(2,3)4)24-16(23)21-7-6-13-14(21)8-12(18)9-19-13/h6-9,11H,10H2,1-5H3 |
| InChIKey | QJNMVTJZFAMAHN-UHFFFAOYSA-N |
| XLogP | 4.04 |
| TPSA | 73.66 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 412.28 |
| LogP ≤ 5 | 4.04 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154645958 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.